7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Hemarthrosis D006395 1 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Prosthesis Failure D011475 1 associated lipids
Tooth Mobility D014086 2 associated lipids
Diabetic Neuropathies D003929 5 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Hip Dislocation D006617 1 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Coronary Stenosis D023921 6 associated lipids
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Mandibular Injuries D008338 1 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Bacteremia D016470 9 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
Cleidocranial Dysplasia D002973 1 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Gingival Recession D005889 2 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Jaw, Edentulous, Partially D007576 1 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Hashimoto Disease D050031 1 associated lipids
Osteolysis, Essential D010015 1 associated lipids
Arthralgia D018771 8 associated lipids
Osteophyte D054850 2 associated lipids
Hemophilia A D006467 10 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Encephalitis D004660 15 associated lipids
Macular Degeneration D008268 5 associated lipids
Mitral Valve Insufficiency D008944 4 associated lipids
Mitral Valve Stenosis D008946 3 associated lipids
Actinomycosis D000196 2 associated lipids
Dental Pulp Exposure D003789 1 associated lipids
Diabetic Foot D017719 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Angina, Stable D060050 2 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Dyslipidemias D050171 7 associated lipids
Stomatitis D013280 14 associated lipids
Weight Loss D015431 56 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Respirovirus Infections D010253 3 associated lipids
Thinness D013851 11 associated lipids
Obesity, Morbid D009767 8 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Mastocytoma D034801 3 associated lipids
Tooth Migration D014085 2 associated lipids
Synovitis, Pigmented Villonodular D013586 1 associated lipids
Chondroblastoma D002804 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Tinnitus D014012 4 associated lipids
Cherubism D002636 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Tooth Resorption D014091 1 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Labyrinthitis D007762 2 associated lipids
Dentin Dysplasia D003805 1 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Foot Injuries D018409 1 associated lipids
Angioid Streaks D000793 1 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
POEMS Syndrome D016878 1 associated lipids
Bone Diseases, Developmental D001848 2 associated lipids
Rheumatic Fever D012213 1 associated lipids
Progeria D011371 3 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Periostitis D010522 1 associated lipids
Urologic Neoplasms D014571 2 associated lipids
Dermatomyositis D003882 2 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Venous Thrombosis D020246 11 associated lipids
Bone Diseases, Endocrine D001849 1 associated lipids
Microvascular Angina D017566 2 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Chronic Disease D002908 7 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Carcinosarcoma D002296 7 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Carcinoid Heart Disease D002275 1 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Koufany M et al. The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway. 2013 Arthritis Rheum. pmid:23982996
Naumnik B et al. Age and gender predict OPG level and OPG/sRANKL ratio in maintenance hemodialysis patients. 2013 Adv Med Sci pmid:23959668
Chen X et al. Environmental level of cadmium exposure stimulates osteoclasts formation in male rats. 2013 Food Chem. Toxicol. pmid:23954550
pmid:23943168
Pichler K et al. Towards a better understanding of bone bridge formation in the growth plate - an immunohistochemical approach. 2013 Connect. Tissue Res. pmid:23941205
Horshuns'ka MIu et al. [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. 2013 May-Jun Ukr Biokhim Zh (1999) pmid:23937044
Zhang J et al. Feeding blueberry diets to young rats dose-dependently inhibits bone resorption through suppression of RANKL in stromal cells. 2013 PLoS ONE pmid:23936431
Crosley LK et al. The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. 2013 Mol Nutr Food Res pmid:23934705
pmid:23934086
Kim SD et al. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. 2013 Biochem. Pharmacol. pmid:23928189
Steensma MR et al. Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy. 2013 PLoS ONE pmid:23922683
Kim HR et al. The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients. 2013 Nephron Clin Pract pmid:23921088
Nile CJ et al. Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease. 2013 J. Clin. Periodontol. pmid:23919740
Bauer S et al. Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study. 2013 Epilepsy Res. pmid:23916144
Albu A et al. Bone metabolism regulators and arterial stiffness in postmenopausal women. 2013 Maturitas pmid:23916080
Pacifici R Osteoimmunology and its implications for transplantation. 2013 Am. J. Transplant. pmid:23915249
Naranjo-Suarez S et al. Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status. 2013 Mol. Cells pmid:23912593
Enhos S et al. OPG and RANKL levels around miniscrew implants during orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23910201
Lekesiz K et al. Effect of unfractionated heparin, enoxaparin and sulodexide on the relations between secretion and expression of OPG, RANKL and vWF in HUVEC. 2013 Folia Histochem. Cytobiol. pmid:23907946
Thormann U et al. Bone formation induced by strontium modified calcium phosphate cement in critical-size metaphyseal fracture defects in ovariectomized rats. 2013 Biomaterials pmid:23906515
Szymczak J and Bohdanowicz-Pawlak A Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate. 2013 Horm. Metab. Res. pmid:23888411
Canalis E et al. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling. 2013 J. Biol. Chem. pmid:23884415
Esteghamati A et al. Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23877020
Zhou S et al. Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway. 2013 PLoS ONE pmid:23874840
Salbach-Hirsch J et al. The promotion of osteoclastogenesis by sulfated hyaluronan through interference with osteoprotegerin and receptor activator of NF-κB ligand/osteoprotegerin complex formation. 2013 Biomaterials pmid:23871544
Dahl JS et al. Relation of osteoprotegerin in severe aortic valve stenosis to postoperative outcome and left ventricular function. 2013 Am. J. Cardiol. pmid:23871267
Cao H et al. Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery. 2013 Ann. Thorac. Surg. pmid:23870696
Wei CC et al. Total glucosides of paeony prevents juxta-articular bone loss in experimental arthritis. 2013 BMC Complement Altern Med pmid:23870279
pmid:23869744
Steagall WK et al. Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. 2013 Am. J. Pathol. pmid:23867796
Zhou J et al. [Effect of sinusoidal electromagnetic fields on rats femur tissue cultivation in vitro]. 2013 Sheng Wu Yi Xue Gong Cheng Xue Za Zhi pmid:23865319
Mogi M and Kondo A The presence of RANKL-OPG complex in human osteosarcoma U2OS. 2013 J Immunoassay Immunochem pmid:23859786
Wang Q et al. The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women. 2013 Int. Immunopharmacol. pmid:23856613
Riesco M et al. Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures. 2013 Clin. Rheumatol. pmid:23846386
Zhang PF et al. Interrelationship of circulating matrix metalloproteinase-9, TNF-α, and OPG/RANK/RANKL systems in COPD patients with osteoporosis. 2013 COPD pmid:23845033
Xiong Q et al. [Effects of recombinant human osteoprotegerin and recombinant RANK protein on the differentiation of osteoclast precursors]. 2013 Zhongguo Gu Shang pmid:23844495
de Araújo Júnior RF et al. Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis. 2013 PLoS ONE pmid:23843954
Puato M et al. Impact of hypertension on vascular remodeling in patients with psoriatic arthritis. 2014 J Hum Hypertens pmid:23842084
Zhu J et al. The influence of g.19124G>a genetic polymorphism in the OPG gene on bone mineral density in Chinese women. 2013 Genet Test Mol Biomarkers pmid:23837846
Xu F et al. Adipocytes regulate the bone marrow microenvironment in a mouse model of obesity. 2013 Mol Med Rep pmid:23835909
Baud'huin M et al. Osteoprotegerin: multiple partners for multiple functions. 2013 Cytokine Growth Factor Rev. pmid:23827649
pmid:23826645
Fu YX et al. Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions. 2013 J. Vet. Sci. pmid:23820214
Meneghini M et al. Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation. 2013 Transplantation pmid:23812001
pmid:23805811
Gordin D et al. Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. 2013 Diabetes Care pmid:23801795
Welldon KJ et al. Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. 2013 Mol. Cell. Endocrinol. pmid:23791847
Anastasilakis AD et al. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. 2013 J. Clin. Endocrinol. Metab. pmid:23788684
Ghaffari S et al. The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography. 2013 Cardiol J pmid:23788300
Liu M et al. Semen Astragali Complanati- and Rhizoma Cibotii-enhanced bone formation in osteoporosis rats. 2013 BMC Complement Altern Med pmid:23782721
Zhang Y et al. Expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on osteoclasts and its potential role in rheumatoid arthritis. 2013 Clinics (Sao Paulo) pmid:23778340
Løgstrup BB et al. Microvascular dysfunction is associated with plasma osteoprotegerin levels in patients with acute myocardial infarction. 2013 Coron. Artery Dis. pmid:23777975
pmid:23775573
Araújo AA et al. Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. 2013 Naunyn Schmiedebergs Arch. Pharmacol. pmid:23775504
Neunaber C et al. Differentiation of osteoprogenitor cells is affected by trauma-haemorrhage. 2013 Injury pmid:23773407
Jiang XY et al. TNFRSF11B polymorphisms are associated with metabolic traits in Uyghur and Han ethnic groups. 2014 Endocr. Res. pmid:23772656
Weiss RM et al. Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. 2013 PLoS ONE pmid:23762316
Lee HJ et al. Association between polymorphisms in leptin, leptin receptor, and β-adrenergic receptor genes and bone mineral density in postmenopausal Korean women. 2014 Menopause pmid:23760429
Pateinakis P et al. Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients. 2013 BMC Nephrol pmid:23758931
Antonoglou G et al. Serum osteoprotegerin and periodontal destruction in subjects with type 1 diabetes mellitus. 2013 J. Clin. Periodontol. pmid:23758409
Takeuchi S et al. Acidosis inhibits mineralization in human osteoblasts. 2013 Calcif. Tissue Int. pmid:23754489
Ostrowska Z et al. Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. 2013 Postepy Hig Med Dosw (Online) pmid:23752595
Xi L et al. OPG/RANK/RANKL axis in atrial fibrillation. 2013 Cardiology pmid:23752030
Tao H et al. OPG/RANK/RANKL axis as a potential therapeutic target for atrial fibrillation. 2013 Cardiology pmid:23751957
Janda K et al. [The relationship between advancement of secondary hyperparathyroidism and selected calcification parameters in peritoneal dialysis patients]. 2012 Prz. Lek. pmid:23750431
Danks L and Takayanagi H Immunology and bone. 2013 J. Biochem. pmid:23750028
Rahnama M et al. Influence of hormone replacement therapy on osteoprotegerin and receptor activator of nuclear factor kappa-B ligand concentrations in menopausal women. 2013 J. Interferon Cytokine Res. pmid:23745763
Shen Q et al. Curculigoside promotes osteogenic differentiation of bone marrow stromal cells from ovariectomized rats. 2013 J. Pharm. Pharmacol. pmid:23738728
LaCroix AZ et al. OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational Study. 2013 Bone pmid:23735608
Wu X et al. Screening of osteoprotegerin-related feature genes in osteoporosis and functional analysis with DNA microarray. 2013 Eur. J. Med. Res. pmid:23731710
Recht M et al. The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption. 2013 Haemophilia pmid:23731369
Wan S Editorial comment: The end of all our exploring ... 2013 Eur J Cardiothorac Surg pmid:23729753
Saini V et al. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. 2013 J. Biol. Chem. pmid:23729679
Kim J et al. Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis. 2013 Clin. Biochem. pmid:23726804
Brzóska MM and Rogalska J Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats. 2013 Toxicol. Appl. Pharmacol. pmid:23726800
Marshall AJ et al. Long-chain triazolyl acids as inhibitors of osteoclastogenesis. 2013 Bioorg. Med. Chem. pmid:23726411
Sagar DR et al. Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. 2014 Ann. Rheum. Dis. pmid:23723320
Hakimi M et al. The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients. 2013 Int. J. Mol. Med. pmid:23722820
Ding Q and Zhang FQ [Effect of icariin on the expression of receptor activator nuclear factor-κB ligand and osteoprotegerin of human periodontal ligament cells]. 2013 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:23714056
pmid:23710898
Luo J et al. 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. 2013 Biomed Res Int pmid:23710436
Uehara H et al. Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin. 2013 Int. J. Oncol. pmid:23708710
Mercatali L et al. RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study. 2013 Int J Mol Sci pmid:23702841
pmid:23701481
Suliburska J et al. The association of insulin resistance with serum osteoprotegerin in obese adolescents. 2013 J. Physiol. Biochem. pmid:23695991
Lou Z et al. Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone. 2013 Med. Oncol. pmid:23690270
Rody WJ et al. Differences in the gingival crevicular fluid composition between adults and adolescents undergoing orthodontic treatment. 2014 Angle Orthod pmid:23687969
Fu YX et al. Influence of osteoprotegerin on differentiation, activation, and apoptosis of Gaoyou duck embryo osteoclasts in vitro. 2013 Poult. Sci. pmid:23687158
Jiang S et al. Changes of blood parameters associated with bone remodeling following experimentally induced fatty liver disorder in laying hens. 2013 Poult. Sci. pmid:23687138
Olivares-Navarrete R et al. Rough titanium alloys regulate osteoblast production of angiogenic factors. 2013 Spine J pmid:23684238
Kato R et al. Gap-junction-mediated communication in human periodontal ligament cells. 2013 J. Dent. Res. pmid:23677649
Jun AY et al. Tetrahydrofurofuran-type lignans inhibit breast cancer-mediated bone destruction by blocking the vicious cycle between cancer cells, osteoblasts and osteoclasts. 2014 Invest New Drugs pmid:23673814
Galeone A et al. Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures. 2013 Eur J Cardiothorac Surg pmid:23671202
Marano RJ et al. Prolactin expression in the cochlea of aged BALB/c mice is gender biased and correlates to loss of bone mineral density and hearing loss. 2013 PLoS ONE pmid:23667691
Kim JY et al. Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress. 2013 Arthritis Rheum. pmid:23666878
Ding CZ et al. [Effects of zhengqing fengtongning tablet and methotrexate on the serum OPG/RANKL and IL-17 of collagen-induced arthritis rats]. 2013 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:23646485
Xie GQ et al. Relationship between serum TGF-β1, OPG levels and osteoporotic risk in native Chinese women. 2013 Clin. Chim. Acta pmid:23643930
Kaludjerovic J and Ward WE Adequate but not supplemental folic acid combined with soy isoflavones during early life improves bone health at adulthood in male mice. 2013 J. Nutr. Biochem. pmid:23643520
Chandran V et al. Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis. 2013 J. Rheumatol. pmid:23637322
Bradaschia-Correa V et al. Reduced RANKL expression impedes osteoclast activation and tooth eruption in alendronate-treated rats. 2013 Cell Tissue Res. pmid:23636419

Table of Content